Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
Clinical trial NCT07093710 · RECRUITING
Trial details
- NCT number
- NCT07093710
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-27
- Primary completion
- 2027-08-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.